The relation between lipoprotein(a) [Lp(a)] as an independent risk factor for coronary atherosclerosis and the severity and extension of angiographically detectable coronary atherosclerotic lesions has not been systematically evaluated. In 118 male patients (54.3±7.4 years) with suspected coronary artery disease and without a history of myocardial infarction undergoing coronary angiography, the relation between plasma Lp(a) levels and other lipoproteins and the severity and extension of coronary lesions was studied. The coronary angiograms were evaluated in a blinded manner according to three scores: vessel score (0 to 3 points for 0 to 3 vessels with stenoses a 70%), stenosis score (0 to 32 points; number and severity of coronary stenoses or lesions), and extent score (0 to 100 points; length-extension of all coronary lesions in relation to the total coronary vessel length). The score values obtained
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A correlation also exists between Lp(a) level and the presence or absence of clinically or angiographically defined coronary artery disease (CAD). 5 - 6 ' 1720 Based on these observations, the purpose of the present study was to analyze whether high Lp(a) levels also correlate with the presence and extension of small but angiographically detectable atherosclerotic coronary lesions, including lesions that represent coronary sclerosis rather than stenosing CAD. In clinical practice, the angiographic diagnosis of CAD is usually based on the presence or absence of more or less circumscribed reductions of the coronary artery luminal diameter of 50% or more, and thus, the diagnosis of CAD is attributed only to patients with relevant coronary stenoses. Coronary lesions visualized in angiography by luminal irregularities of a relatively low degree, sometimes very diffusely distributed in the coronary vascular tree, will be missed by this definition. The method of Sullivan et al 21 scores coronary angiograms to reflect the extent of coronary atherosclerosis by quantifying the length-extension of all angiographically visible coronary lesions as a percentage of the length-extension of the total coronary system. This scoring system was used in the present study to test whether, in a consecutive series of men undergoing coronary angiography for clinical indication, plasma Lp(a) levels correlate with the length-extension of all angiographicalry visible coronary lesions as a proportion of the total coronary vascular tree. Additionally, coronary angiograms were evaluated according to two conventional coronary scores that reflect the severity and number of significant coronary lesions.
Methods

Study Design and Patients
A consecutive series of 173 male patients s65 years of age who were undergoing coronary angiography at our institution was screened for inclusion in this study. Patients having a history of myocardial infarction or coronary artery bypass surgery or who were on lipid-lowering drugs at the time of admission were excluded from study entry. Thus, 118 of 173 (68.2%) patients were included in the study. History, physical examination, and routine laboratory evaluation were performed at the beginning of the study to determine the relation between plasma Lp(a) level, other lipid parameters, known cardiovascular risk factors, clinical evidence of atherosclerosis, or metabolic abnormalities and the extent of coronary alterations. Systolic and diastolic blood pressures, height, weight, presence or absence of diabetes, smoking history, and drug prescription were recorded. Clinical history and physical examination data were entered into a computerized database.
Biochemical Methods
Blood samples for laboratory evaluation were drawn after a 10-hour fast before any heparinization or intravascular contrast medium administration since this might be of relevance for plasma Lp(a) level determinations. Total cholesterol, trigrycerides, and high-density lipoprotein (HDL) cholesterol were measured by using enzymatic assays and a precipitation method from Boehringer Mannheim on a Hitachi 737 autoanalyzer. 22 For HDL determination, LDL and very-low-density lipoproteins were precipitated with phosphotungstate-manganese chloride. The values of LDL cholesterol were calculated by the Friedewald formula if triglycerides were <4.56 mmol/ L. 23 Plasma Lp(a) levels were measured by the use of rocket immunoelectrophoresis (Immuno) by using anti-sera controls and standards. An Lp(a) plasma level of <20 mg/dL was defined as being normal. 24 
Coronary Angiography
Cine coronary angiograms were obtained by using the Judkins technique by experienced examiners. Nitroglycerin (0.2 mg) was injected selectively in the right and left coronary ostia before imaging. Coronary angiograms comprehended at least 7 projections of the left and at least 3 projections of the right coronary arterial tree, with 2 projections each being in a rectangular orientation. Thirty-five-millimeter films were obtained by a 25-frames/s exposition. Cine films were processed in the conventional manner.
Scoring of Coronary Angiograms
Scoring was performed according to three techniques including one new scoring system. 21 (1) Vessel score. Each of the main coronary arterial branches (left anterior descending, left circumflex artery, and right coronary artery) having at least one stenosis ^70% received one point each. The left main stem was regarded as one vessel. If only the left main stem was affected, and the left anterior descending artery and the left circumflex artery and their side branches were normal, the score was counted as 1 point. If the left main stem and the left anterior and/or the left circumflex area were affected, this was counted as 2 points. Thus, the maximum vessel score was 3. (2) Stenosis score. 2327 The maximum diameter reduction of eight coronary segments (left main stem, left anterior descending artery, main diagonal branch, main septal branch, left circumflex artery, main marginal branches, right coronary artery, and right posterior descending branch) was scored with 1 to 4 points each according to a luminal narrowing of 1% to 49% (1 point), 50% to 74% (2 points), 75% to 99% (3 points), or total occlusion (4 points). Points were added to a maximum of 32 points per patient. (3) Extent score. This score was developed by Sullivan et al. 21 Each vessel segment in the coronary vascular tree was graded with different maximum numbers of points: 5 points for left main coronary artery, 20 for left anterior descending artery, 10 for main diagonal branch, 5 for the first septal perforator, 20 for the left circumflex artery, 10 for obtuse marginal and posterolateral vessels, 20 for the right coronary artery, and 10 for the right posterior descending branch. If a marginal branch or an intermediate branch was the predominant vessel for the lateral wall, 20 points were attributed to this vessel, and the left circumflex artery was reduced to 10 points. For each segment the number of points scored was determined by identifying the length proportion of each segment affected by any angiographically visible sign of atheroma as a percentage of total segment length. Alterations may correspond to high-grade stenotic areas or merely luminal irregularities. Thus, a left anterior descending artery with luminal irregularities in 20% of its length-extension was graded with a score of 0.2 (20% length-extension of alterations) times 20 points (maximum point score), ie, a score of 4 points for this particular vessel segment. The same score would be reached, alternatively, with the same vessel having a subtotal stenotic area of 10% length-extension and another area of 30% diameter reduction with 10% length-extension. The scores for all vessel segments mentioned were added for each patient, resulting in scores of 0 to 100 per patient. Occluded vessels, which were filled with contrast medium by collateral flow, were scored according to the irregularities seen. If no collateral flow was present, the mean value of all other vessel segments of this particular patient was attributed to this vessel segment. This method of scoring expresses the length-extension of any visible alteration in a coronary arterial tree rather than giving information about the number and degree of luminal stenoses.
Coronary angiograms were independently reviewed by two experienced cardiologists blinded to the patients' clinical or laboratory findings. The three scores were not derived by values obtained from the routine angiography report but by separate evaluation. Extent score had a variation between two scores of 9±7% in our study, and the intraobserver variability was tested in 10 patients with a variability of less than 5%.
Statistical Analysis
An explorative data analysis was performed by using the STATISTICAL PACKAGE FOR THE SOCIAL SCIENCES (SPSS-X) 28 and the STATISTICAL ANALYSIS SYSTEM (SAS). 29 Bivariate relations of stenosis and extent scores with other variables were calculated by Pearson correlation coefficients and those between vessel score and other variables by ANOVA. Multiple regression analysis was employed for multivariate analysis, with stenosis and extent scores as the dependent variable. For the ordinal dependent-variable vessel score, a logistic multiple regression model was employed. The natural logs of the triglyceride, fibrinogen, and Lp(a) levels; the stenosis and extent scores; and the LDL/HDL cholesterol ratio were used to normalize the distribution. All P values are two-tailed. The significance level is /"<.05 if not otherwise specified.
Results
Baseline Characteristics
The baseline characteristics of the study group are listed in Table 1 . The median age of the study population was 54 years; 14.4% were aged below 45 years. Mean values of systolic and diastolic blood pressures and blood glucose level were within the normal range. However, 11.0% of the population had a systolic blood pressure of 141 to 159 mm Hg and 5.1% had a diastolic blood pressure of 91 to 94 mm Hg, values that are defined by the World Health Organization as signifying borderline hypertension. Thus, 45.7% of the patients were either borderline or definitely hypertensive. The maximum fasting blood glucose level was 16.98 mmol/L (median, 5.49 mmol/L). A total of 39.8% of the patients had never smoked. The body mass index (BMI; ratio of body weight to the square of body height) was ^25 in 33.9% of the patients. Defining overweight as BMI>25, 66.2% of patients were overweight, whereas only 10.2% exhibited obesity when BMI was defined as &30. Prior to hospital admission, almost all patients (98.3%) had received at least one chronic medication (Table 1) . Additionally, drug history was evaluated according to the categories "never taken," "taking at admission," and "taken earlier, not continued." Of the 118 patients, 65.3% had never taken /3-blockers. The corresponding percentages were 45.8% for acetylsalicylic acid, 53.4% for calcium antagonists, and 59.3% for nitrates. Table 3 shows the distribution of vessel, stenosis, and extent scores in the patient population. Whereas 58.5% had no coronary stenosis £70%, resulting in a vessel score of 0, 3.4% had stenoses &70% in three main coronary vessels. One third (33.1%) had no detectable coronary alterations at all, and about two thirds of the population had coronary atherosclerotic alterations in 20% length-proportion of the total coronary tree. 
Serum Lipids
Distribution of Coronary Scores
Relation of Coronary Scores to Clinical and Laboratory Findings
Results of bivariate correlation analysis of clinical and laboratory findings in relation to either vessel, stenosis, or extent scores are shown in Table 4 . There was a significant positive correlation of patient age and Lp(a) level (In) to all three scores used. A nonsignificant negative relation to stenosis score and extent score was obtained for HDL cholesterol and, interestingly, for smoking history and BMI. Systolic blood pressure had a significant positive correlation with stenosis score (P<.05). Besides age (i><.001) and Lp(a) (P<.05), total cholesterol (P<.05), LDL cholesterol (P<.05), and LDLVHDL cholesterol ratio (P<.05) showed a significant positive correlation with the extent score.
Multivariate Analyses
The significant positive relation of the Lp(a) level (In) to all three coronary scores was confirmed in logistic function analysis (vessel score) and in multiple regression analyses (stenosis and extent scores), respectively, taking into consideration the variables age, total cholesterol, LDL/HDL cholesterol ratio (In), and systolic blood pressure. Besides age, which also showed significant positive correlations, in multivariate analysis no other parameter correlated significantly with all three scores used (Table 5) .
Distribution of Lp(a) Values in Relation to Coronary Scores
In Table 6 , the population was divided into patients having normal Lp(a) levels (<20 mg/dL; n=80) and those having elevated Lp(a) levels (^20 mg/dL; n=38). The relative percentage of patients having vessel scores of either 1, 2, or 3 was markedly higher in the patient group with elevated Lp(a) in contrast to patients having a vessel score of 0. For stenosis score, the percentage of scores of 0 to 5 points was higher in the group with low Lp(a), whereas scores between 6 and 10, between 11 and 15, and of more than 15 were more frequently found in patients with elevated Lp(a). Extent scores of 0 to 20 were more often attributed to the patient group with low Lp(a), whereas extent scores of 21 to 40, 41 to 60, or more than 60 points each were obtained more frequently with elevated Lp(a). The relative proportion of 0 values, for all three scores, was at least about one third higher in the low-Lp(a) patient group.
Discussion
The present study was undertaken to assess whether, in a male population undergoing coronary angiography for clinically suspected CAD, there is a relation between Lp(a) plasma levels as an independent predictor for CAD and not only the number of high-grade coronary stenoses but also the proportion of the coronary endothelial surface affected by atherosclerotic lesions with minor luminal narrowing. The results of our study show that these relations exist and can be confirmed by multivariate analyses.
Study Population and Patient Selection
Patients with clinically documented previous myocardial infarction and patients on lipid-lowering drugs were excluded from the study. It is, however, not possible to exclude some bias because prior to admission to our institution all patients were seen by their family doctors. These visits may have influenced certain behaviors, eg, dietary habits, during the waiting time for coronary angiography or led to initiation of a medical therapy, eg, for hypertension. This may partially explain the missing relation between the coronary score values and the LDL or total cholesterol levels obtained at hospital admission. Such changes would, however, have no effect on the Lp(a) plasma levels, as they are remarkably constant despite dietary treatment.
30
Quantification of Coronary Lesions
Although coronary angiography is not able to recognize the earliest steps in the pathogenesis of coronary atherosclerosis, which is characterized by an aggregation of lipid-rich macrophages and T lymphocytes within the innermost layer of the artery wall at a site of endothelial injury, 31 it is able to detect small luminal alterations. These alterations may be regarded as an early step on the way to clinically symptomatic CAD, which, later in its development, is characterized by hemodynamically relevant high-grade stenoses. The extent score used in our study 21 can describe minor luminal irregularities. We did not use quantitative coronary angiography because it focuses on relatively circumscribed stenoses; more importantly, it cannot describe the total coronary artery tree with regard to length proportions even when using multiple angiographic projections of a coronary segment.
Relation of Clinical and Laboratory Findings to Coronary Scores
By using bivariate analyses and logistic function analysis or multiple regression analysis, respectively, significant positive correlations to all three coronary scores were obtained for patient age (vessel score, P<.05; stenosis score, P<.001; extent score, Z'<.001) and Lp(a) (hi) (vessel score, P<.01; stenosis score, P<.01; extent score, / > <.O5). Total cholesterol, LDL cholesterol, and the LDL/HDL cholesterol ratio were significantly related to extent score in bivariate correlation analysis. With multivariate analyses, however, this correlation was not confirmed for total cholesterol (nor LDL or low HDL cholesterol, respectively), whereas the LDL/HDL cholesterol ratio still showed a significant correlation with extent score (P<.05). As mentioned above, the missing relation between the coronary scores obtained and the LDL or total cholesterol levels obtained at hospital admission may be a result of changed dietary behavior during the waiting time for coronary angiography. This missing relation, however, has been confirmed by other studies. 32 - 33 Romm et al 32 used stepwise multiple logistic regression analysis to study 125 men and 72 women undergoing diagnostic coronary angiography. For men, HDL cholesterol was the only variable associated with the presence of CAD (defined as narrowing of ^25% in at least one major coronary artery). They did not include plasma Lp(a) levels in their analysis. The fact that in contrast to their study, HDL cholesterol was not related to the extent of discrete coronary sclerosis in our study, which was the case for Lp(a) level and LDL/HDL cholesterol ratio, may lead to the hypothesis that low HDL cholesterol alone is an important parameter in later stages of CAD and in prediction of severe coronary end points rather than in the earlier stages of the disease, which are represented by the extent score used in our study. In comparison, in 29 women and 103 men Sullivan et al 21 also found no significant relation between HDL cholesterol and extent score and, similar to our data, a negative relation to obesity and a nonsignificant relation to smoking habits, respectively. Admittedly, the evaluation of smoking habits by obtaining the patient history as performed in our study may have some problems with regard to reliability. Age and Lp(a), however, seem to be independent variables already related to a discrete angiographic manifestation of atherosclerosis in the coronary vascular system.
Relation of Plasma Lp(a) Levels to Coronary Atherosclerosis
A relation between Lp(a) levels and the existence of significant CAD has been documented, 5 -617 -20 although two recent prospective studies failed to show this relation. 34 - 35 The question of whether Lp(a) is a causal factor or just a marker of the arteriosclerotic process, however, has not been definitely answered although many studies have tried. Under the presumption that Lp(a) is indeed a causal factor, whether Lp(a) is atherogenic or thrombogenic or both still needs clarification. There is increasing evidence that Lp(a) is able to transverse the endothelium and accumulate in the arterial intima and that apo(a) is localized near fibrin or fibrinogen. 36 The presence of apo(a) may contribute to atherogenesis by promoting the transformation of macrophages into foam cells, 16 which are involved in the very early phase of atherosclerosis. 31 Lp(a) is an independent risk factor for intimal and medial thickening in the carotid arteries of asymptomatic individuals 37 and has been found in atheromatous lesions of human aorta and coronary arteries. 38 -39 Macrophages in culture internalize and poorly degrade Lp(a), and cholesterol loading of macrophages markedly enhances the internaJization and lysosomal degradation of Lp(a) by a calcium-dependent receptor different from known lipoprotein receptors. 40 These data suggest an involvement of Lp(a) in the pathogenesis of atherosclerosis as a primarily atherogenic factor. On the other hand, some data show a linkage of high plasma Lp(a) levels to clot formation or impaired spontaneous thrombolysis. In a model of artery stenosis and thrombosis induction in carotid arteries of monkeys, immunohistochemical analyses have shown incorporation of Lp(a) into the adventitia, media, and intima, and high Lp(a) levels were associated with the occurrence of occlusive arterial thrombus. 41 High Lp(a) concentrations of sometimes more than 300 mg/dL have also been found in patients with myocardial infarction and angiographically normal coronary arteries, 42 which supports the idea that Lp(a) is involved in the thrombotic pathogenesis of coronary occlusion, as might be assumed by its partial homology to plasminogen and its effect of reducing tissue-type plasminogen activator-mediated clot lysis. 43 - 44 In another study, 45 however, newly referred hyperlipidemic patients exhibited no relation between Lp(a) levels and inhibition of regulators of basal and stimulated fibrinoh/tic activity or D-dimer, a measure of in vivo fibrinoh/sis.
The relation found in the present study between Lp(a) and the extension of even minor, nonstenosing atheromatous plaques can be regarded as an index for the relation of Lp(a) to the early, still clinically asymptomatic steps of the pathogenesis of what will become clinically significant coronary heart disease. Future studies should define the potential atherogenic component in L(a). Based on the present study, however, it can be stated that in male patients undergoing coronary angiography for suspected CAD a definite relation exists between Lp(a) levels and the length-extension of coronary atheroma and, thus, the angiographic distribution of lesions in CAD.
